Key result
Cardiac rehabilitation fails to improve fasting glucose in patients with diabetes.
Why the study?
The study evaluated the current control of diabetes in patients completing contemporary cardiac rehabilitation programs across Spain using the prospective ReCardio national registry.
Does a contemporary cardiac rehabilitation program improve diabetes control and metabolic parameters in patients with ischaemic heart disease?
Population
First 244 adult patients with ischaemic heart disease completing a CR program across seven Spanish centres
Comparison
Discharge vs baseline metrics
Design
Prospective, multicentre, cross-sectional registry
Authors
Loading...
Stable glycaemic control in diabetic CR patients supports current management; leaves open causal effects of SGLT2 inhibitors in prospective trials.
Cross-Sectional (n=244)
Yes
Does a contemporary cardiac rehabilitation program improve diabetes control and metabolic parameters in patients with ischaemic heart disease?
Absolute Event Rate: 117% vs 116.5%
p-value: p=NS
Contemporary cardiac rehabilitation programs in Spain maintain stable, acceptable glycaemic control in patients with ischaemic heart disease and diabetes, though targeted interventions may be needed for further optimization.
Fernandez et al. (2026) conducted a cross-sectional in Ischaemic heart disease (n=244). Cardiac rehabilitation program vs. Start of cardiac rehabilitation (baseline) was evaluated on Mean fasting glucose in patients with diabetes (mg/dL) (p=NS). In patients with diabetes completing a cardiac rehabilitation program, mean fasting glucose showed no significant change from the start to the end of the program (116.5 vs. 117.0 mg/dL).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: